Trial Profile
A study evaluating 18F-AV-1451 PET imaging in pre-dementia Parkinson's disease patients
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 13 Jul 2017
Price :
$35
*
At a glance
- Drugs Flortaucipir-F-18 (Primary)
- Indications Mild cognitive impairment; Parkinson's disease
- Focus Diagnostic use
- 13 Jul 2017 New trial record
- 08 Jun 2017 Results presented at the 21st International Congress of Parkinson's Disease and Movement Disorders